Compare RVSN & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RVSN | BNGO |
|---|---|---|
| Founded | 2016 | 2003 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Laboratory Analytical Instruments |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.9M | 24.3M |
| IPO Year | 2022 | 2018 |
| Metric | RVSN | BNGO |
|---|---|---|
| Price | $0.38 | $1.52 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.33 |
| AVG Volume (30 Days) | ★ 734.0K | 192.4K |
| Earning Date | 02-03-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $776,000.00 | ★ $28,720,000.00 |
| Revenue This Year | $28.46 | N/A |
| Revenue Next Year | $755.09 | $24.56 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.27 | $1.45 |
| 52 Week High | $2.72 | $22.80 |
| Indicator | RVSN | BNGO |
|---|---|---|
| Relative Strength Index (RSI) | 51.79 | 38.02 |
| Support Level | $0.33 | $1.61 |
| Resistance Level | $0.37 | $1.63 |
| Average True Range (ATR) | 0.03 | 0.07 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 55.94 | 0.00 |
Rail Vision Ltd is a development-stage technology company that is engaged in the design, development, and assembly of railway detection systems designed to solve the challenges in railway operational safety, efficiency, and predictive maintenance. Its railway detection systems include different types of cameras, including optics, visible light spectrum cameras (video), and thermal cameras that transmit data to a ruggedized onboard computer which is designed to be suitable for the rough environment of a train's locomotive. It has developed its railway detection and systems to save lives, increase efficiency, and dramatically reduce expenses for the railway operator.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.